vimarsana.com

Page 2 - இஸ்ரேல் அமைச்சகம் ஆஃப் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MIGAL Galilee Research Institute Receives EUR 7 5M EU HORIZON 2020 Grant to Develop Algae-Based Pharmaceutical Solutions & Functional Foods

Share this article Share this article Grant to support MIGAL s groundbreaking research into treatments for Colitis and Crohn s Disease led by Dr. Dorit Avni QIRYAT SHMONA, Israel, Feb. 1, 2021 /PRNewswire/  The MIGAL Galilee Research Institute (MIGAL) a regional mega-R&D center supported by Israel s Ministry of Science and Technology, today announced that ALGAE4IBD, a project initiated, led and coordinated by Dr. Dorit Avni, the group leader of MIGAL s Bioactive Metabolites and Immune Modulation Laboratory, has been awarded a prestigious EU (European Union) HORIZON 2020 R&D grant in the amount of EUR 7.5 million. The aim of the grant is to promote a breakthrough in the development of natural ingredients from algae, leveraging their unique capabilities to develop novel treatments for inflammatory diseases with no existing cures, such as Inflammatory Bowel Disease (IBD); Colitis and Crohn s Disease. 

Green med diet cuts non-alcoholic fatty liver disease by half - Ben-Gurion U study

 E-Mail IMAGE: MRI photos illustrate the green MED diet effect on hepatic fat loss A green Mediterranean (MED) diet reduces intrahepatic fat more than other healthy diets and cuts non-alcoholic fatty liver. view more  Credit: Gut 2021 BEER-SHEVA, Israel.January 18, 2021 - A green Mediterranean (MED) diet reduces intrahepatic fat more than other healthy diets and cuts non-alcoholic fatty liver disease (NAFLD) in half, according to a long-term clinical intervention trial led by Ben-Gurion University of the Negev researchers and a team of international colleagues. The findings were published in Gut, a leading international journal focused on gastroenterology and hepatology. Our research team and other groups over the past 20 years have proven through rigorous randomized long-term trials that the Mediterranean diet is the healthiest, says lead researcher Prof. Iris Shai, an epidemiologist in the BGU School of Public Health who is also an adjunct professor at the Harv

Israel, Sweden sign deal to boost tech, scientific research cooperation - World News

2020-12-15 13:35:22 GMT2020-12-15 21:35:22(Beijing Time) Xinhua English JERUSALEM, Dec. 15 (Xinhua) Israel and Sweden have signed an agreement on boosting technological and scientific research cooperation, Israel s Ministry of Science and Technology said on Tuesday. The deal was signed by the Israeli ministry and the Swedish Foundation for Strategic Research (SSF). It includes areas of marine, aerospace, industrial technologies, storage and conversion of water and energy, molecular biology, biotechnology, pharmaceuticals, software, communications and internet, autonomous vehicles, advanced sensor materials, electronics, and eco-friendly materials. Besides strengthening scientific and technological cooperation, the agreement provides the first framework for promoting and supporting ideas and researches by both governments, the Israeli ministry noted.

Israel Cancer Research Fund announces 2020-2021 research grants

Israel Cancer Research Fund announces 2020-2021 research grants NEW YORK, N.Y.–Israel Cancer Research Fund ( ICRF) has announced funding for 69 cancer research grants, valued at $4,711,335, that will be supported for the 2020-2021 funding year.  The new grants include: the first Career Development Award (CDA) for a young clinician-scientist, co-funded with Conquer Cancer (The ASCO Foundation), as well as two new International Collaboration Grants for an Israeli scientist partnering with a U.S.-based scientist, co-funded with The Samuel Waxman Cancer Research Foundation and The Alan B. Slifka Foundation, and two new Gesher Grants for Israeli scientists returning to Israel after studying abroad, co-funded by ICRF Israel and The Israel Ministry of Science and Technology (MOST).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.